Brokerages forecast that Hydrogenics Co. (NASDAQ:HYGS) (TSE:HYG) will post earnings per share of ($0.13) for the current quarter, according to Zacks. Two analysts have issued estimates for Hydrogenics’ earnings, with estimates ranging from ($0.15) to ($0.11). Hydrogenics also reported earnings per share of ($0.13) during the same quarter last year. The company is scheduled to issue its next earnings results on Friday, May 10th.

According to Zacks, analysts expect that Hydrogenics will report full-year earnings of ($0.43) per share for the current financial year, with EPS estimates ranging from ($0.58) to ($0.26). For the next year, analysts expect that the business will report earnings of $0.12 per share, with EPS estimates ranging from $0.01 to $0.23. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side analysts that follow Hydrogenics.

Hydrogenics (NASDAQ:HYGS) (TSE:HYG) last issued its quarterly earnings results on Friday, March 15th. The energy company reported ($0.20) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.23) by $0.03. The firm had revenue of $10.48 million for the quarter, compared to analyst estimates of $10.05 million. Hydrogenics had a negative net margin of 39.35% and a negative return on equity of 81.90%.

HYGS has been the topic of a number of research reports. Canaccord Genuity initiated coverage on shares of Hydrogenics in a research note on Wednesday, January 16th. They issued a “speculative buy” rating and a $8.75 price target on the stock. HC Wainwright set a $8.00 price target on shares of Hydrogenics and gave the company a “buy hygs” rating in a research note on Monday, December 24th. ValuEngine raised shares of Hydrogenics from a “buy” rating to a “strong-buy” rating in a research note on Monday, December 31st. Roth Capital lowered shares of Hydrogenics from a “buy” rating to a “neutral” rating and set a $7.00 price target on the stock. in a research note on Wednesday, January 30th. Finally, Zacks Investment Research upgraded shares of Hydrogenics from a “sell” rating to a “hold” rating in a report on Tuesday, January 8th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the stock. Hydrogenics currently has an average rating of “Hold” and an average target price of $8.56.

Hydrogenics stock traded up $0.11 during midday trading on Friday, reaching $8.40. The company had a trading volume of 26,590 shares, compared to its average volume of 39,059. The firm has a market capitalization of $159.47 million, a PE ratio of -9.77 and a beta of 0.83. Hydrogenics has a 12-month low of $3.80 and a 12-month high of $9.10.

An institutional investor recently bought a new position in Hydrogenics stock. Renaissance Technologies LLC acquired a new stake in Hydrogenics Co. (NASDAQ:HYGS) (TSE:HYG) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 18,300 shares of the energy company’s stock, valued at approximately $133,000. Renaissance Technologies LLC owned about 0.12% of Hydrogenics at the end of the most recent quarter. 16.45% of the stock is owned by institutional investors and hedge funds.

Hydrogenics Company Profile

Hydrogenics Corporation, together with its subsidiaries, designs, develops, and manufactures hydrogen generation products based on water electrolysis technology; and fuel cell products based on proton exchange membrane technology. It operates in two segments, OnSite Generation and Power Systems. The OnSite Generation segment develops products for industrial gas, hydrogen fueling, and renewable energy storage markets.

See Also: What is included in the gross domestic product?

Get a free copy of the Zacks research report on Hydrogenics (HYGS)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Hydrogenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hydrogenics and related companies with's FREE daily email newsletter.